Co-localization analysis of ASCL1 and OLIG2 double+ cells in terminal tumors showed that while only 64% of OLIG2+ tumor cells are ASCL1+, 86% of ASCL1+ tumor cells were OLIG2+ (Supplementary Fig. 2m). This evidence concerns the gene OLIG2 and neoplasm.